CARLUCCIO, Erberto
 Distribuzione geografica
Continente #
NA - Nord America 1.595
EU - Europa 1.346
AS - Asia 354
Continente sconosciuto - Info sul continente non disponibili 4
Totale 3.299
Nazione #
US - Stati Uniti d'America 1.592
IE - Irlanda 342
IT - Italia 235
SE - Svezia 226
UA - Ucraina 213
HK - Hong Kong 185
VN - Vietnam 92
RU - Federazione Russa 80
FI - Finlandia 56
CN - Cina 54
FR - Francia 54
DE - Germania 49
BE - Belgio 33
GB - Regno Unito 21
CH - Svizzera 13
AT - Austria 9
KR - Corea 8
PL - Polonia 6
UZ - Uzbekistan 5
EU - Europa 4
CA - Canada 3
JP - Giappone 3
NL - Olanda 3
CZ - Repubblica Ceca 2
SG - Singapore 2
TR - Turchia 2
YE - Yemen 2
GR - Grecia 1
LB - Libano 1
PT - Portogallo 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
Totale 3.299
Città #
Chandler 426
Dublin 333
Hong Kong 184
San Mateo 172
Jacksonville 112
Perugia 98
Dong Ket 92
Altamura 79
Medford 78
Princeton 78
Lawrence 64
Wilmington 60
Ann Arbor 58
Andover 56
Saint Petersburg 42
Beijing 35
Brussels 33
Woodbridge 19
New York 17
Falls Church 14
Des Moines 12
Los Angeles 12
Norwalk 12
Redwood City 11
Helsinki 8
Houston 8
San Paolo di Civitate 8
Lappeenranta 7
Ashburn 6
Boardman 6
Frankfurt Am Main 6
Lausanne 6
Florence 5
Guangzhou 5
Menlo Park 5
Shanghai 5
Nanning 4
Auburn Hills 3
Peccioli 3
Seoul 3
Bari 2
Bologna 2
Brno 2
Den Haag 2
Empoli 2
Esslingen am Neckar 2
Huskvarna 2
Izmir 2
Kagoya 2
Lucca 2
Milan 2
Moscow 2
Poznan 2
Redmond 2
Rome 2
Sanaa 2
Zhengzhou 2
Amsterdam 1
Bolzano Vicentino 1
Bratislava 1
Cambridge 1
Cascina 1
Dallas 1
Fairfield 1
Figline Valdarno 1
Gangbuk-gu 1
Gualdo Tadino 1
Ottawa 1
Philadelphia 1
Phoenix 1
Pisa 1
Rostock 1
Ruvo Di Puglia 1
San Benedetto Del Tronto 1
San Diego 1
Sant'agata De' Goti 1
Sassari 1
Seattle 1
Secaucus 1
Selargius 1
Torino 1
Toronto 1
Totale 2.244
Nome #
Atrial fibrillation in hypertension: predictors and outcome 100
Effect of revascularizing viable myocardium on left ventricular diastolic function in patients with ischaemic cardiomyopathy. 96
Patients with hibernating myocardium show altered left ventricular volumes and shape, which revert after revascularization: evidence that dyssynergy might directly induce cardiac remodeling. 81
Relationship between contractile reserve and diastolic function in hibernating myocardium 76
Impact of metabolic syndrome on presentation and evolution of acute coronary syndromes 72
Improved cardiovascular risk stratification by a simple ECG index in hypertension 69
Apoptosi: come si può controllare la morte cellulare programmata e che benefici possiamo attenderci sul cuore? 67
Prognostic value of residual pulmonary congestion at discharge assessed by lung ultrasound imaging in heart failure 67
Prognostic value of left ventricular hypertrophy and geometry in patients with a first, uncomplicated myocardial infarction 65
Blood pressure variability: relation with sex and age. 65
Fibrosis assessment by integrated backscatter and its relationship with longitudinal deformation and diastolic function in heart failure with preserved ejection fraction 62
Effects of Metabolic Syndrome on Pattern of Acute Coronary Syndromes 61
Long term follow up of acute coronary syndromes in patients with metabolic syndrome: differences between stemi vs nstemi 60
Elevated serum uric acid concentration at discharge confers additive prognostic value in elderly patients with acute heart failure 59
Advantages of deformation indices over systolic velocities in assessment of longitudinal systolic function in patients with heart failure and normal ejection fraction. 58
Prognostic value of pulmonary congestion assessed by lung ultrasound imaging during heart failure hospitalisation: A two-centre cohort study 57
Arresto cardiaco ipocinetico ed ipereosinofilia: sindrome di Kounis o sindrome di Churg-Strauss? 54
Atrial Function in Patients Undergoing CRT REPLY 53
Effects of acute myocardial ischemia on QT dispersion by dipyridamole-stress echocardiography 53
Left Atrial Reservoir Function and Outcome in Heart Failure With Reduced Ejection Fraction 52
[Dyslipidemia as cardiovascular and cerebrovascular risk factor: epidemiology and physiopathology] 50
C-reactive protein as a marker for cardiac ischemic events in the year after a first, uncomplicated myocardial infarction. 50
Prognostic Value of Right Ventricular Dysfunction in Heart Failure With Reduced Ejection Fraction: Superiority of Longitudinal Strain Over Tricuspid Annular Plane Systolic Excursion 50
Angiotensin–neprilysin inhibition in heart failure with preserved ejection fraction 50
Fattori che influenzano la presentazione elettrocardiografica e l'evoluzione clinica delle sindromi coronariche acute. 49
Superior Prognostic Value of Right Ventricular Free Wall Compared to Global Longitudinal Strain in Patients With Heart Failure 49
La fibrinolisi nella terapia dell'infarto acuto del miocardio. Dai grandi trials alla pratica clinica: Risultati dell'U.O. di Cardiologia del Policlinico Monteluce di Perugia su 1151 pazienti consecutivi 48
Different correlates but similar prognostic implications for right ventricular dysfunction in heart failure patients with reduced or preserved ejection fraction 48
Microcirculation in hypertension 44
Valore prognostico dei livelli ematici di BNP nello scompenso cardiaco: stratificazione prognostica basata sulla combinazione tra riduzione percentuale e valore assoluto del BNP alla dimissione 44
Prognostic relevance of Doppler echocardiographic re-assessment in HFrEF patients 44
Adjuvant trastuzumab cardiotoxicity in patients over 60 years of age with early breast cancer: A multicenter cohort analysis 43
Role of endothelial dysfunction in heart failure 43
Echo and natriuretic peptide guided therapy improves outcome and reduces worsening renal function in systolic heart failure: An observational study of 1137 outpatients 42
Improvement of myocardial performance (Tei) index closely reflects intrinsic improvement of cardiac function: assessment in revascularized hibernating myocardium. 42
Echo and BNP serial assessment in ambulatory heart failure care: Data on loop diuretic use and renal function 42
Global longitudinal strain in heart failure with reduced ejection fraction: Prognostic relevance across disease severity as assessed by automated cluster analysis 42
Valore prognostico del BNP nello scompenso cardiaco: importanza del raggiungimento di uno stato di euvolemia. 41
Long term follow-up of acute coronary syndrome in patients with Metabolic Syndrome. 41
Presence of extensive LV remodeling limits the benefits of CRT in patients with intraventricular dyssynchrony. 41
Correlazioni tra riserva contrattile e pattern di riempimento diastolico transmitralico nel miocardio ibernato. 41
Pre-existing type 2 diabetes is associated with increased all-cause death independently of echocardiographic predictors of poor prognosis only in ischemic heart disease 41
Low-dose dipyridamole infusion acutely increases exercise capacity in angina pectoris: a double-blind, placebo controlled crossover stress echocardiographic study. 41
EFFETTI DELLA TERAPIA CRONICA CON NITRODERIVATI NEI PAZIENTI CON SINDROMI CORONARICHE ACUTE 40
Exercise elicits dynamic changes in extravascular lung water and haemodynamic congestion in heart failure patients with preserved ejection fraction 40
Practical considerations on anticoagulation reversal: spotlight on the reversal of dabigatran 40
Valore prognostico del BNP nello scompenso cardiaco: confronto fra variazione percentuale dei livelli ematici dall'ingresso alla predimissione e valore assoluto in predimissione 39
The 'Echo Heart Failure Score': an echocardiographic risk prediction score of mortality in systolic heart failure. 39
Improvement in TEI Index closely mirrors reversal of left ventricular dysfunction in chronic ischemic cardiomyopathy. 38
Usefulness of the severity and extent of wall motion abnormalities as prognostic markers of an adverse outcome after a first myocardial infarction treated with thrombolytic therapy 37
Machine learning analysis of left ventricular function to characterize heart failure with preserved ejection fraction 36
Prognostic Value of Dynamic Changes in Pulmonary Congestion During Exercise Stress Echocardiography in Heart Failure With Preserved Ejection Fraction 36
Gestione computerizzata del paziente sottoposto ad ecocardiografia con stress farmacologico 36
Relation between contractile riserve and diastolic function in hibernating myocardium. 35
Non-cardiac factors for prediction of response to cardiac resynchronization therapy: The value of baseline, and of serial changes, in red cell distribution width 35
Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure 35
Exercise-induced B-lines in heart failure with preserved ejection fraction occur along with diastolic function worsening 35
Commentary: Elucidating the mechanisms underlying left ventricular function recovery in patients with ischemic heart failure undergoing surgical remodeling: Physiology versus Empiricism 34
Burden of Ventricular Arrhythmias in CRT-D and ICD Recipients with Recovered Left Ventricular Ejection Fraction: the Additive Role of Speckle Tracking Echocardiography. 34
Combining echo and natriuretic peptides to guide heart failure care in the outpatient setting: A position paper 33
Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic study 33
Prognostic Value of Right Ventricular Dysfunction on Clinical Outcomes After Transcatheter Aortic Valve Replacement 29
Characteristics, treatment, and outcomes of newly diagnosed atrial fibrillation patients with heart failure: GARFIELD-AF 29
Left atrial structural and mechanical remodelling in heart failure with reduced ejection fraction 28
Echocardiographically defined haemodynamic categorization predicts prognosis in ambulatory heart failure patients treated with sacubitril/valsartan 28
Il miglioramento del Tei-index rispecchia strettamente il recupero della disfunzione ventricolare sinistra in pazienti con cardiomiopatia ischemica cronica. 27
Reproducibility of echocardiographic assessment of 2D-derived longitudinal strain parameters in a population-based study (the STANISLAS Cohort study) 27
Trastuzumab adjuvant chemotherapy and cardiotoxicity in real-world women with breast cancer 27
[The NEAT-HFpEF study] 26
Prognostic value of nt-probnp, and echocardiographic indices of diastolic function, in hospitalized patients with acute heart failure and preserved left ventricular ejection fraction 26
Right ventricular recovery during follow-up is associated with improved survival in patients with chronic heart failure with reduced ejection fraction 24
Left Atrial Strain in the Assessment of Diastolic Function in Heart Failure: A Machine Learning Approach 23
Management of heart failure in the new era: The role of scores 22
The left ventricle as a mechanical engine: From Leonardo da Vinci to the echocardiographic assessment of peak power output-to-left ventricular mass 21
Unraveling the relationship between serum uric acid levels and cardiovascular risk 20
Prognostic role of left ventricular ejection fraction in heart failure: Back to the future? 20
Effects of SGLT2 inhibitors on cardiac structure and function 19
Risk stratification of Asian patients with heart failure and reduced ejection fraction: the effectiveness of the Echo Heart Failure Score 16
Sacubitril/valsartan reduces indications for arrhythmic primary prevention in heart failure with reduced ejection fraction: insights from DISCOVER-ARNI, a multicenter Italian register 14
Left ventricular remodeling response to SGLT2 inhibitors in heart failure: an updated meta-analysis of randomized controlled studies 13
A strange case of Transthyretin Cardiac Amyloidosis in the Elderly: a diagnostic challenge 12
Non-invasive assessment of acute heart failure by Stevenson classification: Does echocardiographic examination recognize different phenotypes? 11
Role of hypertension on new onset congestive heart failure in patients receiving trastuzumab therapy for breast cancer. 11
Deformation Imaging by Strain in Chronic Heart Failure Over Sacubitril-Valsartan: A Multicenter Echocardiographic Registry 10
Right heart failure in left heart disease: imaging, functional, and biochemical aspects of right ventricular dysfunction 8
Different right ventricular dysfunction and pulmonary coupling in acute heart failure according to the left ventricular ejection fraction 8
BLITZ-HF: a nationwide initiative to evaluate and improve adherence to acute and chronic heart failure guidelines 8
Patient phenotype profiling using echocardiography and natriuretic peptides to personalise heart failure therapy 8
Sacubitril/Valsartan in Heart Failure with Reduced Ejection Fraction: Real-World Experience from Italy (the REAL.IT Study) 8
Pharmacoutilization and adherence to sacubitril/valsartan in real world: the REAL.IT study in HFrEF 5
Effect of sacubitril/valsartan on cardiac remodeling compared with other renin-angiotensin system inhibitors: a difference-in-difference analysis of propensity-score matched samples 4
Methods in diagnosing heart failure 3
Right Heart Remodeling and Outcomes in Patients With Tricuspid Regurgitation: A Literature Review and Meta-Analysis 2
Totale 3.545
Categoria #
all - tutte 13.629
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.629


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201910 0 0 0 0 0 0 0 0 0 0 9 1
2019/2020267 20 4 30 10 43 5 35 8 28 53 2 29
2020/2021600 6 27 31 32 159 58 37 15 61 29 41 104
2021/2022756 19 110 9 55 27 10 10 229 21 71 92 103
2022/20231.235 86 227 10 139 96 123 6 49 450 8 32 9
2023/2024393 20 84 26 22 4 2 157 4 55 19 0 0
Totale 3.545